JPRN-UMIN000019252招募中未知
Investigation of the secretion of glucagon for glucose intolerance - Investigation of the secretion of glucagon for glucose intolerance
Kobe university school of medicine, Diabetes and Endocrinoplogy0 个研究点目标入组 105 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type 1 DM 2)Pancreatic diabetes 3)Medical history of gastrointestinal tract surgery 4)Having insulin antibody(>10%) 5)Treatment with any long-acting insulin 6)Treatment with steroid 7)Impaired liver function, defined as alanine aminotransferase >2 times upper limit of normal(HBC or HCV infection) 8) Impaired renal function defined as eGFR <60ml/min 9) Severe cardiac dysfunction (> NYHA 3) 10)Cancer and medical history of cancer 11)Pregnancy or breast feeding 12)Known or suspected abuse of alcohol, narcotics or illicit drugs 13)Mental retardation or dementia or other inappropriate persons judged by investigators
研究者
相似试验
已完成
不适用
Alternation in glucagon secretion associated with progression of glucose intolerance.normal glucose tolerance, impaired glucose metabolism, Type 2 diabetes mellitus (non-insulin dependent)JPRN-UMIN000016133Kitasato University School of Medicine53
招募中
不适用
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label,prospective exploratory trialtype 1 diabetesJPRN-UMIN000039635agasaki University Hospital24
尚未招募
不适用
Investigating the role of the glucagon-like peptide 1 system on foodcue-induced brain activation – a non-interventional longitudinalfunctional magnetic resonance imaging studyE66.9Obesity, unspecifiedDRKS00033360Zentralinstitut für Seelische Gesundheit, Klinik für Abhängiges Verhalten und Suchtmedizin, repräsentiert durch60
已完成
不适用
Effect of glucagon-like-peptide-1 (GLP-1) on left ventricular function during percutaneous coronary intervention (PCI)ISRCTN77442023Papworth Hospital NHS Foundation Trust (UK)40
已完成
不适用
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.Type 2 diabetesJPRN-UMIN000007378Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine200